17
Participants
Start Date
August 1, 2023
Primary Completion Date
August 6, 2024
Study Completion Date
August 6, 2024
Rapid Expiratory Occlusion Monitor (REOM)
Device for which Health Canada approval (ITA Authorization) has been obtained for use in the present study.
Standard oscillometry
tremoflo device-100, Thorasys Thoracic Medical Systems Inc., Montreal, Canada
Standard pulmonary function test
Standard-of-care respiratory test.
McGill University Health Centre, Montreal
McGill University
OTHER
Thorasys Thoracic Medical Systems Inc.
INDUSTRY
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER